Cosmetics Business Feature (June 2026): Eight New Peptide-Anchored Beauty Launches Tracked: Shiseido Ultimune Power Infusing Oil, YSE Beauty Xtreme Glow Dewy Peptide Plumping Serum ($68), K-Beauty PDRN-Peptide-Exosome Stack Defining 2026 Skincare
Cosmetics Business published an industry feature in June 2026 cataloging eight peptide-anchored beauty launches during the year's first half, framing 2026 as the year topical peptide skincare crossed from prestige-only to mass-market shelves. Tracked launches include Shiseido's refreshed Ultimune Power Infusing Oil (a serum-format extension of the brand's signature resilience line), YSE Beauty's Xtreme Glow Dewy Peptide Plumping Serum ($68, the company's best first-day and first-week launch by units), and adjacent product categories anchored on PDRN (polydeoxyribonucleotide), exosomes, and acetyl-hexapeptide and palmitoyl-tripeptide blends. AOL and Glossy parallel coverage flagged the K-beauty PDRN-peptide-exosome stack as the defining ingredient combination for 2026 (matched against retinol on efficacy claims, against snail mucin on heritage positioning). The cosmetic-peptide commercial wave runs alongside the regulatory wave: the FDA peptide categories under PCAC review (BPC-157, KPV, TB-500, MOTS-C, Emideltide, Semax, Epitalon) include several with cosmetic-adjacent claims, and the Moes Group / CKYN / GELITA / Italgel manufacturing pipeline tracked in June digests anchors the supply side.